Indication
Chronic Pulmonary Aspergillosis
7 clinical trials
10 products
Product
IbrexafungerpClinical trial
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)Status: Completed, Estimated PCD: 2023-08-17
Clinical trial
Use of Voriconazole Inhalation Powder for the Treatment of Pulmonary AspergillosisStatus:
Product
VoriconazoleClinical trial
A Randomized Controlled Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Increasing Time to Relapse in Patients With Chronic Pulmonary Aspergillosis Treated With 12 Months of Oral ItraconazoleStatus: Recruiting, Estimated PCD: 2026-06-03
Product
Normal salineProduct
Amphotericin BClinical trial
A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary AspergillosisStatus: Completed, Estimated PCD: 2024-05-31
Product
ItraconazoleClinical trial
Therapeutic Efficacy Comparison of a Six-month Treatment by Itraconazole and Nebulised Ambisome® Versus Treatment by Itraconazole Alone in Non- or Mildly- Immunocompromised Patients With Chronic Pulmonary Aspergillosis: a Prospective, Randomized, Single Blind Study, (Single Aspergilloma Excluded)Status: Recruiting, Estimated PCD: 2027-06-01
Product
AmbisomeProduct
Inhaled PlaceboClinical trial
A Randomized Controlled Trial to Compare Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in Chronic Pulmonary and Allergic Bronchopulmonary Aspergillosis Overlap SyndromeStatus: Recruiting, Estimated PCD: 2024-12-31
Product
PrednisoneClinical trial
Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility StudyStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Product
Interferon Gamma-1BProduct
Antifungals